BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim JW, Olive S, Jones S, Thillai M, Russell AM, Johnson MJ, Wilson A. Interstitial lung disease and specialist palliative care access: a healthcare professionals survey. BMJ Support Palliat Care 2020:bmjspcare-2019-002148. [PMID: 32561550 DOI: 10.1136/bmjspcare-2019-002148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Gersten RA, Seth B, Arellano L, Shore J, O'hare L, Patel N, Safdar Z, Krishna R, Mageto Y, Cochran D, Lindell K, Danoff SK, Patel D, Whelan TP, Adams T, Reichuber J, Russell T, Bachert H, Luckhardt TR, Morrison L, Dematte JE, Gripaldo RE, Henderson M, Thavarajah K, Tomic R. Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease. Chest 2022;162:375-384. [DOI: 10.1016/j.chest.2022.03.009] [Reference Citation Analysis]
2 Chai GT, Neo HY, Abisheganaden J, Hum AYM. Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients. Am J Hosp Palliat Care 2022;:10499091221083575. [PMID: 35389277 DOI: 10.1177/10499091221083575] [Reference Citation Analysis]
3 Palmer E, Kavanagh E, Visram S, Bourke AM, Forrest I, Exley C. Which factors influence the quality of end-of-life care in interstitial lung disease? A systematic review with narrative synthesis. Palliat Med 2021;:2692163211059340. [PMID: 34920685 DOI: 10.1177/02692163211059340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kalluri M. Specialty Palliative Care Program ILD. Respiratory Medicine 2021. [DOI: 10.1007/978-3-030-81788-6_16] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wijsenbeek MS, Moor CC. Palliative Care in Interstitial Lung Disease. Respiratory Medicine 2021. [DOI: 10.1007/978-3-030-81788-6_11] [Reference Citation Analysis]